New York Medical College is a private biomedical health sciences university based in Valhalla, New York. Founded in 1860, it is a member of the Touro College and University System.

During the past decade, New York Medical College/Westchester Medical Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New York Medical College/Westchester Medical Center" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials, followed by "Nicole Hamblett" with 3 trials sponsored, "Bioverativ, a Sanofi company" with 2 trials sponsored, "New York Medical College" with 2 trials sponsored and "Ophtec USA" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York Medical College/Westchester Medical Center" #1 collaborator was "Cystic Fibrosis Foundation" with 5 trials as a collaborator, "University of Washington" with 2 trials as a collaborator, "Community Programs for Clinical Research on AIDS" with 1 trials as a collaborator, "Dartmouth-Hitchcock Medical Center" with 1 trials as a collaborator and "The Emmes Company, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "New York Medical College/Westchester Medical Center" are "HIV Infections" (6 trials), "Cystic Fibrosis" (5 trials), "Aphakia" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials) and "Acute Myeloid Leukemia (AML)" (1 trials). Many other conditions were trialed in "New York Medical College/Westchester Medical Center" in a lesser frequency.

Most popular intervention types in "New York Medical College/Westchester Medical Center" are "Drug" (19 trials), "Device" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Artisan Aphakia Intraocular Lens" (2 trials), "Delavirdine mesylate" (2 trials), "Placebo" (2 trials), "YSPSL" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "New York Medical College/Westchester Medical Center" are 26 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "New York Medical College/Westchester Medical Center". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in New York Medical College/Westchester Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New York Medical College/Westchester Medical Center, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".